SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-034454
Filing Date
2018-06-15
Accepted
2018-06-15 17:22:25
Documents
1
Period of Report
2018-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv496606_form4.html 4  
1 FORM 4 tv496606_form4.xml 4 3482
  Complete submission text file 0001144204-18-034454.txt   4853
Mailing Address 464 COMMON STREET SUITE 301 BELMONT MA 02478
Business Address
SALZMAN BARRY M (Reporting) CIK: 0001432179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 18903081

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations